Business | Theatre of blood

The trial of Elizabeth Holmes gets under way

The former boss of a notorious failed health-care startup could face jail

A CROWD OF reporters, drawn by the drama and glamour of the event, jostled outside a courtroom in San Jose on August 31st to witness the opening of what may be the next, perilous, act for a woman once touted as the next Steve Jobs and the world’s youngest self-made female billionaire. Jury selection was beginning for the fraud trial of Elizabeth Holmes, the former boss of Theranos, a startup which attempted to revolutionise the process of blood testing but failed spectacularly in 2016 after the press and regulators probed the company’s inflated claims.

This article appeared in the Business section of the print edition under the headline “Theatre of blood”

The threat from the illiberal left

From the September 4th 2021 edition

Discover stories from this section and more in the list of contents

Explore the edition

Discover more

red shipping container twisted into a knot-like shape, set against a yellow background

How painful will Trump’s tariffs be for American businesses?

Their options range from hoarding goods and raising prices to rewiring supply chains

Pat Gelsinger, chief executive officer of Intel Corp., holds an artificial intelligence processor

Intel’s troubles deepen, as its boss makes an abrupt exit

Pat Gelsinger’s surprise departure poses a dilemma for Donald Trump


Food packaging with "Notpla Coating" is pictured at Notpla.

Could seaweed replace plastic packaging?

Companies are experimenting with new ways to reduce plastic waste


Has Sequoia Capital outgrown its business model?

Venture capital’s hardiest perennial gets back to its roots

On stupid rules and quick wins

Why every boss can benefit from asking employees what most infuriates them